Andreas Wagner Sells 22,238 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 22,238 shares of the firm’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $20.47, for a total value of $455,211.86. Following the completion of the sale, the insider directly owned 169,805 shares of the company’s stock, valued at $3,475,908.35. This represents a 11.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Alignment Healthcare Trading Down 1.7%

Shares of ALHC opened at $20.05 on Friday. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The business has a 50-day moving average of $20.89 and a 200 day moving average of $17.99. The firm has a market cap of $4.01 billion, a P/E ratio of -167.08, a price-to-earnings-growth ratio of 5.20 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. KeyCorp reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 22nd. JPMorgan Chase & Co. boosted their price objective on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. UBS Group increased their price objective on Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, January 14th. Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Alignment Healthcare presently has an average rating of “Moderate Buy” and an average price target of $23.32.

Institutional Trading of Alignment Healthcare

Several institutional investors and hedge funds have recently modified their holdings of ALHC. Parallel Advisors LLC boosted its position in shares of Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after acquiring an additional 773 shares during the last quarter. Larson Financial Group LLC bought a new stake in Alignment Healthcare during the third quarter valued at approximately $33,000. First Horizon Corp purchased a new position in Alignment Healthcare in the 4th quarter worth approximately $39,000. GAMMA Investing LLC grew its stake in Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after buying an additional 987 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Alignment Healthcare in the 3rd quarter worth $53,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.